The South America Avian Influenza Vaccine Market is experiencing notable growth driven by technological advancements, increasing awareness of avian influenza's impact, and evolving regulatory frameworks. The market was valued at USD 328.67 million in 2024 and is projected to reach USD 489.47 million by 2035, exhibiting a CAGR of 3.69% during the forecast period. This growth reflects the...